Security key
87978U207
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)
CUSIP: 87978U207
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 13,473,733
- Total 13F shares
- 316,052
- Share change
- -358,732
- Total reported value
- $3,248,899
- Price per share
- $10.28
- Number of holders
- 16
- Value change
- -$2,235,429
- Number of buys
- 10
- Number of sells
- 5
Report period
Q3 2025
Institutions
16
Top holders
10
TPST full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Tempest Therapeutics, Inc. SEC filings
Tempest Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87978U207
Recent filing periods:
Top shareholders of TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
276,587
|
$1,880,792 | — | 30 Jun 2025 | |
| Versant Venture Management, LLC |
13F
|
Company |
1.8%
|
269,772
|
$1,834,450 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
138,962
|
$944,942 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
134,608
|
$915,334 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.29%
|
39,068
|
$265,662 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
34,736
|
$236,214 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.25%
|
33,225
|
$225,930 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
11,223
|
$76,316 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
2,107
|
$14,328 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,834
|
$12,459 | — | 30 Jun 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
1,538
|
$10,412 | — | 30 Jun 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
292
|
$1,986 | — | 30 Jun 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
260
|
$1,768 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
234
|
$1,592 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
56
|
$381 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
33
|
$225 | — | 30 Jun 2025 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
18
|
$122 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3
|
$20 | — | 30 Jun 2025 | |
| Versant Vantage II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,118,644
|
$10,127,118 | — | 29 Apr 2022 | |
| Versant Venture Capital VI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,328,585
|
$2,562,608 | — | 08 Aug 2024 | |
| Rock Springs Capital Management LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
73,654
|
$352,066 | — | 30 Dec 2021 | |
| Stephen R. Brady |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
596,376
mixed-class rows
|
$97,853 | — | 02 Jan 2025 | |
| Samuel Whiting |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
279,573
mixed-class rows
|
$20,390 | — | 02 Jan 2025 | |
| Thomas W. Dubensky |
3/4/5
|
President, Director |
—
class O/S missing
|
102,700
|
— | — | 03 Jan 2023 | |
| Pierre Lorenzo |
3/4/5
|
Corporate Controller |
—
class O/S missing
|
8,477
|
— | — | 21 Jun 2022 | |
| Stella Xu |
3/4/5
|
Director |
—
class O/S missing
|
6,635
|
— | — | 01 Jul 2021 | |
| Thomas Woiwode |
3/4/5
|
Director |
—
class O/S missing
|
3,500
|
— | — | 17 Jun 2022 |
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q3 2025
As of 30 Sep 2025,
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
316,052 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., FMR LLC, DRW Securities, LLC, UBS Group AG, Belvedere Trading LLC, MORGAN STANLEY, OSAIC HOLDINGS, INC., and CIBC Private Wealth Group LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
17
Q3 2025 holders
16
Holder diff
-1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.